These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26478928)

  • 1. Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice.
    Engel M; Snikeris P; Jenner A; Karl T; Huang XF; Frank E
    Int J Neuropsychopharmacol; 2015 May; 18(7):pyu114. PubMed ID: 26478928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine.
    Fejgin K; Pålsson E; Wass C; Svensson L; Klamer D
    Neuropsychopharmacology; 2008 Jul; 33(8):1874-83. PubMed ID: 17895915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.
    O'Tuathaigh CM; Harte M; O'Leary C; O'Sullivan GJ; Blau C; Lai D; Harvey RP; Tighe O; Fagan AJ; Kerskens C; Reynolds GP; Waddington JL
    Eur J Neurosci; 2010 Jan; 31(2):349-58. PubMed ID: 20074216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
    Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
    Kehr J; Yoshitake T; Ichinose F; Yoshitake S; Kiss B; Gyertyán I; Adham N
    Psychopharmacology (Berl); 2018 May; 235(5):1593-1607. PubMed ID: 29637288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.
    Gaskin PL; Toledo-Rodriguez M; Alexander SP; Fone KC
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27382048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
    Abekawa T; Ito K; Nakagawa S; Koyama T
    Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
    Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
    Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide.
    Fejgin K; Pålsson E; Wass C; Finnerty N; Lowry J; Klamer D
    Neuropsychopharmacology; 2009 Jun; 34(7):1673-84. PubMed ID: 19145229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
    Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A
    Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition.
    Klamer D; Pålsson E; Fejgin K; Zhang J; Engel JA; Svensson L
    Psychopharmacology (Berl); 2005 May; 179(2):479-88. PubMed ID: 15619121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
    Abekawa T; Ito K; Koyama T
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.
    Amitai N; Kuczenski R; Behrens MM; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1422-31. PubMed ID: 21238466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine.
    Matsuura A; Fujita Y; Iyo M; Hashimoto K
    Acta Neuropsychiatr; 2015 Jun; 27(3):159-67. PubMed ID: 25648314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 receptor-mediated miRNA-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with Neuregulin-1 expression in mice.
    Wang P; Cao T; Chen J; Jiang Y; Wang C; Waddington JL; Zhen X
    Neuropharmacology; 2019 Oct; 157():107675. PubMed ID: 31233824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ
    Lloyd D; Talmage D; Shannon Weickert C; Karl T
    Pharmacol Biochem Behav; 2018 Jul; 170():64-70. PubMed ID: 29750976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
    Li Z; Boules M; Williams K; Peris J; Richelson E
    Brain Res; 2010 Jan; 1311():28-36. PubMed ID: 19948149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine Prevents the PCP-induced Reduction in the Neurite Outgrowth of Prefrontal Cortical Neurons via NRG1.
    Zhang Q; Yu Y; Huang XF
    Sci Rep; 2016 Jan; 6():19581. PubMed ID: 26781398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
    du Bois TM; Newell KA; Huang XF
    Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.